Shock wave therapy to reduce wrist muscle spasticity after stroke
Official title: Clinical and Ultrasonographic Evaluation of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) in Post-Stroke Spasticity: A Randomized Controlled Trial
Run by Pamukkale University · NCT07119801 · Data updated 2026-11-12
This trial will try radial extracorporeal shock wave therapy to reduce wrist flexor spasticity in adults 35–65 who had a single stroke more than six months ago.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 65 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Pamukkale University Academic / other |
| Locations | 1 site (Denizli) |
| Status | Recruiting |
| Started | September 5, 2025 |
| Main results expected | April 20, 2026 |
| Study ends | December 20, 2026 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07119801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 35–65, more than six months after a first-ever stroke, with wrist flexor spasticity rated MAS 1–3 and no contraindications to ESWT.
✕Probably not a fit
Patients with fixed wrist contractures, severe communication problems, multiple prior strokes, recent botulinum toxin/phenol injections, significant unstable medical conditions, or contraindications to ESWT are unlikely to benefit or to be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Chronic stroke patients with moderate wrist flexor spasticity will receive radial extracorporeal shock wave therapy in addition to conventional rehabilitation, and outcomes will be compared over short-term follow-up. Clinical spasticity will be measured with the Modified Ashworth Scale while ultrasound strain elastography and echogenicity will provide objective measures of muscle stiffness and tissue quality. The protocol excludes patients with fixed contractures, recent botulinum toxin or phenol injections, multiple strokes, or medical contraindications to ESWT. The study aims to correlate clinical changes with ultrasonographic biomarkers to provide more objective evidence of treatment effect.
Why it matters
Potential benefit: If successful, ESWT could provide a noninvasive way to reduce wrist spasticity and improve comfort and function for chronic stroke survivors.
How similar studies have gone: Small trials and case series have reported reductions in post-stroke spasticity with ESWT, but larger, ultrasound-supported randomized data are limited so the approach is promising but not yet definitively proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 35 and 65 years. * First-ever stroke episode confirmed by MRI and/or CT scan. * Clinical diagnosis of hemiplegia. * More than 6 months post-stroke. * A Modified Ashworth Scale (MAS) score between 1 and 3 for wrist flexor spasticity. Exclusion Criteria: * History of more than one stroke episode * Stroke onset more than ten years ago * Stroke onset less than 6 months ago * Age over 65 (to limit the effects of aging on muscle structure) * Contraindications for ESWT (e.g., cancer, local tumor or active infection in the treatment area, pregnancy, coagulation disorders, pacemaker or other electronic/metallic implants) * Severe aphasia or serious communication problems * Presence of fixed contracture in the wrist * Patients who have received botulinum toxin or phenol nerve block injections within the last 6 months * Medically unstable patients (e.g., uncontrolled hypertension, diabetes mellitus, or severe cardiac, hepatic, or renal disease)
Where it's running
-
Pamukkale University
Denizli, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Meltem Güneş Akıncı, Assistant professor
- Email: meltem_aytekin@hotmail.com
- Phone: +905375145590
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.